By proceeding, you agree to our Terms of Use and Privacy Policy.
Sr. Director, Cell Therapy Operations and Patient Services
#Cell #Therapy
#NorthAmerica
Alicia Dixon Sr.
Associate Director, Process Development Cell Therapies
#Cell #Process
Amy Shaw Associate Director, Process Development Cell Therapies at Takeda
Sr Scientist in Analytical Development
#cell #genetherapy #molecularbiology
Enthusiastic and results-oriented Scientific Professional with more than 10 years of biopharmaceutical industry and research experience. Self-motivated and passionate about cell and gene therapy field
Director - Biology
#cellbiology #cell
#Europe
After an education in Biological Science and a Ph.D. in Molecular Oncology, I have spent more than ten years at investigating the complexity of tumor-stroma interactions in order to contribute to defi
Director, Cell-Based Sciences
#drugdiscovery #cell
Effectively turning excellence in science into meaningful improvements of lives ●Biophysicist ●Strategic and operational excellence, successfully developing and implementing short-and long-term strate
Assistant Professor
#biochemistry #cell
Anna Blakney is an Assistant Professor in the Michael Smith Laboratories and School of Biomedical Engineering at UBC. She received her BSc in Chemical & Biological Engineering from the University of C
Senior Scientist II
#cell #biology
Anu Vasudevan is Senior Scientist II, Analytical Development at ArsenalBio
Associate Director
#Cell #GeneTherapyCritical
Basak Clements works at Janssen (Johnson & Johnson) BioTherapeutics Development & Supply, Material Sciences group as an Associate Director.
#assaydevelopment #cell
Dr. Ben Clarke coordinates collaborative for USP’s physical reference standards, for monoclonal antibodies, cell, and gene therapy. Before joining USP, Ben developed potency bioassays at GSK Vaccines
Head of Operations Cell & Gene Therapy Europe
#Cell #Oncology #Hematology
Dr. Bernd Eschgfäller is passionate about providing new treatment options to patients with life-threatening diseases.Bernd is the Head of Cell & Gene Therapy Operations Europe at Novartis.
Executive Director, Co-founder
#biotechnology #cell
#Northamerica
Boro Dropulić has worked in the gene therapy field since the late 1980s. After four years in academic research in the US, he founded his first company, ViRxSys, and led the team that first demonstrate
Executive Vice President, Science and Research
#molecularbiology #cell
Dr. Bradly Wouters is an internationally recognized leader and cancer researcher. He became Executive Vice President of Science and Research at UHN in 2016 and prior to that served as the Interim Dire